Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
1.010
+0.035 (3.58%)
Aug 14, 2026, 3:14 PM EDT - Market open
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $24.17 million as of August 14, 2026. Its market cap has decreased by -86.16% in one year.
Market Cap
24.17M
Enterprise Value
16.03M
1-Year Change
-86.16%
Ranking
Category
Stock Price
$1.01
ChartMarket Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has decreased from $152.13M to $24.17M, a decrease of -84.12%. That is a compound annual growth rate of -60.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 24.17M | -83.01% |
| Dec 31, 2025 | 142.25M | -8.50% |
| Dec 31, 2024 | 155.47M | 2.20% |
| Aug 13, 2024 | 152.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Enlivex | 27.63M |
| Evaxion | 27.44M |
| CEL-SCI | 27.07M |
| Atossa Therapeutics | 25.51M |
| Cerenome | 25.33M |
| Barinthus Biotherapeutics | 24.91M |
| Longeveron | 23.54M |
| Jasper Therapeutics | 22.97M |